The Manufacturers Life Insurance Company Has $1.26 Million Stake in Tilray Inc (NASDAQ:TLRY)

The Manufacturers Life Insurance Company grew its position in Tilray Inc (NASDAQ:TLRY) by 4.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 715,672 shares of the company’s stock after acquiring an additional 33,194 shares during the quarter. The Manufacturers Life Insurance Company owned 0.08% of Tilray worth $1,260,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Bank of Montreal Can lifted its holdings in Tilray by 0.3% during the 3rd quarter. Bank of Montreal Can now owns 2,176,506 shares of the company’s stock worth $3,787,000 after buying an additional 7,406 shares in the last quarter. Estate Counselors LLC increased its holdings in shares of Tilray by 40.0% during the 3rd quarter. Estate Counselors LLC now owns 70,000 shares of the company’s stock worth $123,000 after acquiring an additional 20,000 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. increased its stake in Tilray by 2.6% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,487,500 shares of the company’s stock valued at $2,617,000 after acquiring an additional 37,300 shares during the last quarter. CIBC Asset Management Inc raised its position in Tilray by 4.2% during the 3rd quarter. CIBC Asset Management Inc now owns 908,098 shares of the company’s stock worth $1,599,000 after purchasing an additional 36,799 shares during the last quarter. Finally, Ferguson Wellman Capital Management Inc. acquired a new stake in shares of Tilray during the 3rd quarter worth approximately $26,000. Institutional investors own 9.35% of the company’s stock.

Analyst Ratings Changes

Separately, Roth Mkm dropped their price target on shares of Tilray from $2.00 to $1.75 and set a “neutral” rating on the stock in a research report on Friday, October 11th.

Tilray Price Performance

NASDAQ TLRY opened at $1.26 on Thursday. The company has a market capitalization of $1.14 billion, a PE ratio of -4.67 and a beta of 2.09. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.57 and a current ratio of 2.47. The business’s fifty day moving average is $1.50 and its 200 day moving average is $1.68. Tilray Inc has a fifty-two week low of $1.22 and a fifty-two week high of $2.97.

Tilray (NASDAQ:TLRY) last released its quarterly earnings data on Thursday, October 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.04). The firm had revenue of $200.00 million for the quarter, compared to the consensus estimate of $218.70 million. Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. The company’s quarterly revenue was up 13.0% on a year-over-year basis. During the same period last year, the firm earned ($0.10) earnings per share. Sell-side analysts predict that Tilray Inc will post -0.14 earnings per share for the current year.

Insider Buying and Selling

In other Tilray news, CFO Carl A. Merton bought 26,000 shares of Tilray stock in a transaction dated Friday, November 15th. The stock was acquired at an average cost of $1.36 per share, with a total value of $35,360.00. Following the completion of the acquisition, the chief financial officer now owns 26,000 shares of the company’s stock, valued at approximately $35,360. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.87% of the stock is currently owned by company insiders.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.